Nika A. Kravos
Ljubljana, 1000, Slovenia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Metformin and Insulin Resistance: A Review of the Underlying Mechanisms behind Changes in GLUT4-Mediated Glucose Transport.
Journal: International journal of molecular sciences
Published: December 30, 2021
Effects of metformin withdrawal after long and short term treatment in PCOS: observational longitudinal study.
Journal: Diabetology & metabolic syndrome
Published: December 02, 2020
Long-term efficacy of metformin in overweight-obese PCOS: longitudinal follow-up of retrospective cohort.
Journal: Endocrine connections
Published: November 19, 2019
SLC6A4 5HTTLPR Polymorphism Affects Insulin Secretion in Patients with Polycystic Ovary Syndrome.
Journal: International journal of endocrinology
Published: February 04, 2018
Low serum testosterone is associated with impaired graft function early after heart transplantation.
Low serum testosterone is associated with impaired graft function early after heart transplantation.
Journal: Clinical transplantation
Published: March 13, 2017
Short-term effectiveness of low dose liraglutide in combination with metformin versus high dose liraglutide alone in treatment of obese PCOS: randomized trial.
Journal: BMC endocrine disorders
Published: October 29, 2016
SORCS1 polymorphism and insulin secretion in obese women with polycystic ovary syndrome.
Journal: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
Published: April 08, 2016
Efficacy of CD34+ Stem Cell Therapy in Nonischemic Dilated Cardiomyopathy Is Absent in Patients With Diabetes but Preserved in Patients With Insulin Resistance.
Journal: Stem cells translational medicine
Published: July 27, 2015
Comparison of different methods investigating functional and morphological markers of early atherogenesis in obese women with polycystic ovary syndrome.
Journal: International angiology : a journal of the International Union of Angiology
Published: May 29, 2015
A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome.
Journal: Hormones (Athens, Greece)
Published: April 18, 2015
Last Updated: 09/26/2026